Novartis-and-Argo-Signs-Deal-of-up-to-$5.2b-for-Heart-Drugs

Mod-GRF-1-29-Peptide-Investigating-Its-Potential-in-Scientific-Research
FDA-Approves-Recombinant-VWF-Treatment-in-Pediatric-Patients